CNS Pharmaceuticals Statistics
Total Valuation
CNSP has a market cap or net worth of $2.56 million. The enterprise value is $1.96 million.
| Market Cap | 2.56M |
| Enterprise Value | 1.96M |
Important Dates
The last earnings date was Wednesday, May 15, 2024, after market close.
| Earnings Date | May 15, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CNSP has 11.85 million shares outstanding. The number of shares has increased by 357.00% in one year.
| Shares Outstanding | 11.85M |
| Shares Change (YoY) | +357.00% |
| Shares Change (QoQ) | +131.27% |
| Owned by Insiders (%) | 8.55% |
| Owned by Institutions (%) | 8.21% |
| Float | 9.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.26
| Current Ratio | 0.26 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,163.73 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -575.40% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$5.82M |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -88.25% in the last 52 weeks. The beta is 1.19, so CNSP's price volatility has been higher than the market average.
| Beta (1Y) | 1.19 |
| 52-Week Price Change | -88.25% |
| 50-Day Moving Average | 0.24 |
| 200-Day Moving Average | 0.99 |
| Relative Strength Index (RSI) | 47.86 |
| Average Volume (30 Days) | 454,333 |
Short Selling Information
The latest short interest is 62,455, so 0.53% of the outstanding shares have been sold short.
| Short Interest | 62,455 |
| Short Previous Month | 31,224 |
| Short % of Shares Out | 0.53% |
| Short % of Float | 0.65% |
| Short Ratio (days to cover) | 0.20 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -17.48M |
| Pretax Income | -17.46M |
| Net Income | -17.46M |
| EBITDA | -17.45M |
| EBIT | -17.45M |
| Earnings Per Share (EPS) | -$3.48 |
Balance Sheet
The company has $815,226 in cash and $213,104 in debt, giving a net cash position of $602,122 or $0.05 per share.
| Cash & Cash Equivalents | 815,226 |
| Total Debt | 213,104 |
| Net Cash | 602,122 |
| Net Cash Per Share | $0.05 |
| Equity / Book Value | -4.43M |
| Book Value Per Share | -0.37 |
| Working Capital | -4.49M |
Cash Flow
In the last 12 months, operating cash flow was -$12.51 million and capital expenditures -$3,901, giving a free cash flow of -$12.51 million.
| Operating Cash Flow | -12.51M |
| Capital Expenditures | -3,901 |
| Free Cash Flow | -12.51M |
| FCF Per Share | -$1.44 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CNSP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -357.00% |
| Shareholder Yield | -357.00% |
| Earnings Yield | -681.55% |
| FCF Yield | -488.27% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on November 29, 2022. It was a reverse split with a ratio of 1:30.
| Last Split Date | Nov 29, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |